Cytarabine

ATP binding cassette subfamily B member 1 ; Homo sapiens







27 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 27530244 Severe palmar-plantar erythrodysesthesia and aplasia in an adult undergoing re-induction treatment with high-dose cytarabine for acute myelogenous leukemia: a possible drug interaction between posaconazole and cytarabine. 2017 Sep 1
2 26278546 Synergism of Curcumin and Cytarabine in the Down Regulation of Multi-Drug Resistance Genes in Acute Myeloid Leukemia. 2016 1
3 25567217 Association of ABCB1 polymorphisms with prognostic outcomes of anthracycline and cytarabine in Chinese patients with acute myeloid leukemia. 2015 Mar 1
4 25012726 Association of ABCB1 polymorphisms with the efficacy of ondansetron in chemotherapy-induced nausea and vomiting. 2014 Aug 1 1
5 22829167 Analysis of the interaction of induction regimens with p-glycoprotein expression in patients with acute myeloid leukaemia: results from the MRC AML15 trial. 2011 Jun 4
6 19846953 Rapid induction of P-glycoprotein mRNA and protein expression by cytarabine in HL-60 cells. 2009 Oct 4
7 16837911 Cross-resistance to cytosine arabinoside in human acute myeloid leukemia cells selected for resistance to vincristine. 2006 Jun 9
8 15257929 Clinical effects and P-glycoprotein inhibition in patients with acute myeloid leukemia treated with zosuquidar trihydrochloride, daunorubicin and cytarabine. 2004 Jul 1
9 15347263 Assessment of drug resistance in acute myeloid leukemia. 2004 Sep 1
10 10769646 Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs. 2000 Jan-Feb 5
11 10865967 P-glycoprotein in primary acute myeloid leukemia and treatment outcome of idarubicin/cytosine arabinoside-based induction therapy. 2000 Jun 1
12 11122104 Contrasting in vitro effects for the combination of fludarabine, cytosine arabinoside (Ara-C) and granulocyte colony-stimulating factor (FLAG) compared with daunorubicin and Ara-C in P-glycoprotein-positive and P-glycoprotein-negative acute myeloblastic leukaemia. 2000 Nov 5
13 11426620 Differential effects of the MDR1 (multidrug resistance) gene-activating agents on protein kinase C: evidence for redundancy of mechanisms of acquired MDR in leukemia cells. 2000 Dec 2
14 10361105 Altered multidrug resistance phenotype caused by anthracycline analogues and cytosine arabinoside in myeloid leukemia. 1999 Jun 15 1
15 10500774 MDR1/P-GP expression as a prognostic factor in acute leukemias. 1999 1
16 10500780 Assessment of P-glycoprotein expression by immunocytochemistry and flow cytometry using two different monoclonal antibodies coupled with functional efflux analysis in 34 patients with acute myeloid leukemia. 1999 1
17 10557064 Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines. 1999 Nov 5
18 10561359 Parallel phase I studies of daunorubicin given with cytarabine and etoposide with or without the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age or older with acute myeloid leukemia: results of cancer and leukemia group B study 9420. 1999 Sep 1
19 9052685 60-Hz electric fields inhibit protein kinase C activity and multidrug resistance gene (MDR1) up-regulation. 1997 Mar 2
20 9322679 Expression and functional activity of P-glycoprotein in adult acute myelogenous leukemia patients. 1997 Jul-Aug 3
21 8656697 P-glycoprotein expression in patients with acute leukemia-clinical relevance. 1996 Jul 1
22 8900436 Inhibition of cytarabine-induced MDR1 (P-glycoprotein) gene activation in human tumor cells by fatty acid-polyethylene glycol-fatty acid diesters, novel inhibitors of P-glycoprotein function. 1996 Oct 9 5
23 8996546 Stimulation of 1-(beta-D-arabinofuranosyl)cytosine (AraC)-induced apoptosis in the multidrug resistant human promyelocytic leukemia cell lines with protein kinase inhibitors. 1996 1
24 7516032 Expression of the multidrug resistance P-glycoprotein and its relationship to hematological characteristics and response to treatment in myelodysplastic syndromes. 1994 Jun 1
25 7906380 Cytosine arabinoside and mitoxantrone treatment of relapsed or refractory childhood leukemia: initial response and relationship to multidrug resistance gene 1. 1994 1
26 7914749 Clinical importance of P-glycoprotein-related resistance in leukemia and myelodysplastic syndromes--first experience with their reversal. 1994 2
27 2896069 Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines. 1988 May 15 1